Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments

v3.7.0.1
Financial Instruments
 3 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Financial Instruments
Financial Instruments
The composition of financial instruments is as follows:
 
March 31, 2017
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
Gains
 
Losses
 
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
8,640

 
$
—

 
$
—

 
$
8,640

Government debt securities
26,016

 


 
(35
)
 
25,981

Corporate debt securities
37,676

 
—

 
(20
)
 
37,656

 
72,332

 
—

 
(55
)
 
72,277

Less amounts included in cash and cash equivalents
(8,640
)
 
—

 
—

 
(8,640
)
 
$
63,692

 
$
—

 
$
(55
)
 
$
63,637

 
December 31, 2016
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
Gains
 
Losses
 
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
39,181

 
$
—

 
$
—

 
$
39,181

Government debt securities
28,025

 
—

 
(32
)
 
27,993

Corporate debt securities
25,923

 
—

 
(7
)
 
25,916

 
93,129

 
—

 
(39
)
 
93,090

Less amounts included in cash and cash equivalents
(39,181
)
 
—

 
—

 
(39,181
)
 
$
53,948

 
$
—

 
$
(39
)
 
$
53,909


 
Fair Value at December 31, 2016
 
(in thousands)
Liabilities
 
Contingent consideration
$
375

Total
$
375


At March 31, 2017, the Company held 22 government and corporate debt securities with an aggregate fair value of $44.5 million that were in an unrealized loss position for less than 12 months. No securities have been in unrealized loss positions for greater than 12 months. Gross unrealized losses were immaterial at March 31, 2017, and represented temporary impairments on government agency and corporate debt securities related to multiple issuers, and were primarily caused by fluctuations in U.S. interest rates. The Company evaluates securities for other-than-temporary impairment on a quarterly basis. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include the length of time and extent to which fair value has been less than the cost basis; the financial condition and near-term prospects of the issuer; changes in the financial condition of the security’s underlying collateral; any downgrades of the security by a rating agency; nonpayment of scheduled interest, or the reduction or elimination of dividends; as well as our intent and ability to hold the security in order to allow for an anticipated recovery in fair value.
The fair values of the Company’s financial instruments are the amounts that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants and are recorded using a hierarchal disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The levels are described below:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.
Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
Level 3: Unobservable inputs are used when little or no market data is available.
The Company classifies its financial instruments within Level 1 or Level 2 of the fair value hierarchy on the basis of valuations using quoted market prices or alternate pricing sources and models utilizing market observable inputs, respectively. The Company’s money market funds were valued based on quoted prices for the specific securities in an active market and were therefore classified as Level 1. The government and corporate debt securities have been valued on the basis of valuations provided by third-party pricing services, as derived from such services’ pricing models. The pricing services may use a consensus price which is a weighted average price based on multiple sources or mathematical calculations to determine the valuation for a security, and have been classified as Level 2. The Company reviews Level 2 inputs and fair value for reasonableness and the values may be further validated by comparison to independent pricing sources. In addition, the Company reviews third-party pricing provider models, key inputs and assumptions and understands the pricing processes at its third-party providers in determining the overall reasonableness of the fair value of its Level 2 financial instruments. As of March 31, 2017, the Company has not made any adjustments to the prices obtained from its third party pricing providers. The contingent liability is classified as Level 3 as of December 31, 2016 and is valued using an internal rate of return model. The assumptions used in preparing the internal rate of return model include revenues earned related to Physpeed products and services and a discount factor of 1 at December 31, 2016. The contingent liability was settled in the three months ended March 31, 2017. The assumptions used in preparing the internal rate of return model include estimates for outcome if milestone goals are achieved, the probability of achieving each outcome and discount rates. Significant changes in any of the unobservable inputs used in the fair value measurement of contingent consideration in isolation could result in a significantly lower or higher fair value. A change in estimated future revenues would be accompanied by a directionally similar change in fair value.
The following table presents a summary of the Company’s financial instruments that are measured on a recurring basis:
 
 
 
Fair Value Measurements at March 31, 2017
 
Balance at March 31, 2017
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
8,640

 
$
8,640

 
$
—

 
$
—

Government debt securities
25,981

 
—

 
25,981

 
—

Corporate debt securities
37,656

 
—

 
37,656

 
—

 
$
72,277

 
$
8,640

 
$
63,637

 
$
—

 
 
 
Fair Value Measurements at December 31, 2016
 
Balance at December 31, 2016
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
39,181

 
$
39,181

 
$
—

 
$
—

Government debt securities
27,993

 
—

 
27,993

 
—

Corporate debt securities
25,916

 
—

 
25,916

 
—

 
$
93,090

 
$
39,181

 
$
53,909

 
$
—

Liabilities
 
 
 
 
 
 
 
Contingent consideration
$
375

 
$
—

 
$
—

 
$
375


The following summarizes the activity in Level 3 financial instruments:
 
Three Months Ended March 31,
 
2017
 
2016
 
(in thousands)
Contingent Consideration (1)
 
 
 
Beginning balance
$
375

 
$
395

Physpeed earn-out payment
(375
)
 
(240
)
Loss recognized in net income(2)
—

 
86

Ending balance
$
—

 
$
241

Net loss for the period included in net income attributable to contingent consideration held at the end of the period
$
—

 
$
(86
)
____________________________
(1)
In connection with the acquisition of Physpeed, the Company recorded contingent consideration based upon the expected achievement of 2015 and 2016 revenue milestones. Changes to the fair value of contingent consideration due to changes in assumptions used in preparing the valuation model are recorded in selling, general and administrative expense in the unaudited consolidated statements of income.
(2)
Changes to the estimated fair value of contingent consideration for the three months ended March 31, 2016 were primarily due to updates to present value discount factors.
There were no transfers between Level 1, Level 2 or Level 3 financial instruments in the three months ended March 31, 2017.